Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand–Ir(III) Complex Conjugates

Documenti analoghi

• rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC
  di: Giovanna Polcaro, et al.
  Pubblicazione: (2024-03-01)
• Enhancing Non-small Cell Lung Cancer Susceptibility to Anti-PD-1/PD-L1 Therapy through PD-L1 Ligand–Ir(III) Complex Conjugates
  di: Valentina Pagliara, et al.
  Pubblicazione: (2026-01-01)
• Dissecting the link between PD-1/PD-L1-based immunotherapy and cancer pain: mechanisms, research implications, and artificial intelligence perspectives
  di: Marco Cascella, et al.
  Pubblicazione: (2024-12-01)
• Rs10204525 Polymorphism of the Programmed Death (PD-1) Gene Is Associated with Increased Risk in a Saudi Arabian Population with Colorectal Cancer
  di: Nouf Al-Harbi, et al.
  Pubblicazione: (2022-10-01)
• PD-L1/PD-1 and CTLA-4 Expression in Equine Penile Squamous Cell Carcinomas
  di: Ilaria Porcellato, et al.
  Pubblicazione: (2021-07-01)